* Alignment Healthcare Inc ALHC.OQ ALHC.O is expected
to show
a rise in quarterly revenue when it reports results on November
3.
* The Orange California-based company is expected to report
a
13.6% increase in revenue to $333.399 million from $293.47
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data. The company's guidance on
August 4 2022, for the period ended September 30, was for
revenue between $330.00 million and $335.00 million.
* Refinitiv's mean analyst estimate for Alignment
Healthcare Inc
is for a loss of 25 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Alignment
Healthcare Inc is $20.5, above its last closing price
of $13.68.
The company's guidance on August 4 2022 for the period ended
September 30 was for Earnings before Interest, Taxes,
Depreciation and Amortization of between 330 million and -20
million (USD).
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.26 -0.26 -0.06 Beat 76.7
Mar. 31 2022 -0.25 -0.25 -0.23 Beat 6.5
Dec. 31 2021 -0.31 -0.30 -0.27 Beat 9.6
Sep. 30 2021 -0.17 -0.17 -0.26 Missed -51.5
Jun. -0.11 -0.11 -0.25 Missed -127.3
30 2021
Mar. 31 2021 -0.19 -0.19 -0.35 Missed -84.2
This summary was machine generated November 2 at 02:06 GMT. All
figures in US dollars unless otherwise stated